Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis [Structural Heart Disease]

Conclusions— These findings suggested that TAVR is a feasible treatment for severe aortic stenosis in patients with early-stage liver disease or as bridge therapy before a curative treatment of the hepatic condition. Patients with Child-Pugh class B-C, especially in combination with renal impairment, had a very low survival rate, and TAVR should be carefully considered to avoid a futile treatment. These results may contribute to improve the clinical decision-making process and management in patients with liver disease.
Source: Circulation: Cardiovascular Interventions - Category: Cardiology Authors: Tags: Valvular Heart Disease, Aortic Valve Replacement/Transcatheter Aortic Valve Implantation, Mortality/Survival, Quality and Outcomes Structural Heart Disease Source Type: research